Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Surgeons transplant pig heart into human patient for second time | Warfarin after TAVR | AI-powered drug research
Tuesday, September 26, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Surgeons make history again, transplant pig heart into human patient for second time ever

That same team that transplanted a pig heart into a human patient for the very first time in 2022 has now done it again. The patient is currently recovering from the procedure, which occurred on Sept. 20. 

READ MORE >
Surgeons with University of Maryland Medical Center transplant a pig heart into a human patient for only the second time ever on Sept. 20 2023. Bartley P. Griffith, MD, a professor of surgery and clinical director of the cardiac xenotransplantation program at the University of Maryland School of Medicine (UMSOM), and Muhammad M. Mohiuddin, MD, scientific director of the cardiac xenotransplantation program at UMSOM, performed the historic procedure. #pigheart
Share on Twitter Share on Facebook Share on Linkedin

Surgeons make history again, transplant pig heart into human patient for second time ever

Share on Twitter Share on Facebook Share on Linkedin
Surgeons with University of Maryland Medical Center transplant a pig heart into a human patient for only the second time ever on Sept. 20 2023. Bartley P. Griffith, MD, a professor of surgery and clinical director of the cardiac xenotransplantation program at the University of Maryland School of Medicine (UMSOM), and Muhammad M. Mohiuddin, MD, scientific director of the cardiac xenotransplantation program at UMSOM, performed the historic procedure. #pigheart
That same team that transplanted a pig heart into a human patient for the very first time in 2022 has now done it again. The patient is currently recovering from the procedure, which occurred on Sept. 20. 
READ MORE >

Warfarin after TAVR is safe, but fails to boost outcomes

Researchers examined two-year data from transfemoral TAVR patients treated with low-dose aspirin and 30 days of warfarin or just aspirin on its own. 

READ MORE >
Pills
Share on Twitter Share on Facebook Share on Linkedin

Warfarin after TAVR is safe, but fails to boost outcomes

Share on Twitter Share on Facebook Share on Linkedin
Pills
Researchers examined two-year data from transfemoral TAVR patients treated with low-dose aspirin and 30 days of warfarin or just aspirin on its own. 
READ MORE >

Novo Nordisk spends $60M on advanced AI in search of new cardiovascular medications

Novo Nordisk is working with Valo Health to identify potential new treatments for cardiometabolic conditions. If it proves to be a fruitful collaboration, the initial payment of $60 million will be just the beginning. 

READ MORE >
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).
Share on Twitter Share on Facebook Share on Linkedin

Novo Nordisk spends $60M on advanced AI in search of new cardiovascular medications

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).
Novo Nordisk is working with Valo Health to identify potential new treatments for cardiometabolic conditions. If it proves to be a fruitful collaboration, the initial payment of $60 million will be just the beginning. 
READ MORE >

Featured Articles

Q&A: A closer look at the push in cardiology for a new, independent American Board of Cardiovascular Medicine

American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 

READ MORE >
Illustration of cardiologists going through the certification process. American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 
Share on Twitter Share on Facebook Share on Linkedin

Q&A: A closer look at the push in cardiology for a new, independent American Board of Cardiovascular Medicine

Share on Twitter Share on Facebook Share on Linkedin
Illustration of cardiologists going through the certification process. American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 
American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 
READ MORE >

Pulsed field ablation shows potential to replace thermal ablation

Vivek Reddy, MD, explained that pulsed field ablation is associated with many benefits compared to the current standard of care in electrophysiology. 

READ MORE >
Vivek Reddy, MD, director of arrhythmia service and processor of medicine in cardiac electrophysiology, Mt. Sinai, New York, expolains the key takeaways from the ADVENT trial of pulsed field ablation at ESC 2023.
Share on Twitter Share on Facebook Share on Linkedin

Pulsed field ablation shows potential to replace thermal ablation

Share on Twitter Share on Facebook Share on Linkedin
Vivek Reddy, MD, director of arrhythmia service and processor of medicine in cardiac electrophysiology, Mt. Sinai, New York, expolains the key takeaways from the ADVENT trial of pulsed field ablation at ESC 2023.
Vivek Reddy, MD, explained that pulsed field ablation is associated with many benefits compared to the current standard of care in electrophysiology. 
READ MORE >

FDA approves empagliflozin for treating chronic kidney disease

The popular SGLT2 inhibitor, sold by Boehringer Ingelheim and Eli Lilly and Company under the name Jardiance, has already been approved by the FDA to treat type 2 diabetes and heart failure.

READ MORE >
Damaged Organ
Share on Twitter Share on Facebook Share on Linkedin

FDA approves empagliflozin for treating chronic kidney disease

Share on Twitter Share on Facebook Share on Linkedin
Damaged Organ
The popular SGLT2 inhibitor, sold by Boehringer Ingelheim and Eli Lilly and Company under the name Jardiance, has already been approved by the FDA to treat type 2 diabetes and heart failure.
READ MORE >

In Case You Missed It

Another long-term benefit of AFib ablation: Improved mental health

A new study published in JAMA suggests catheter ablation can help AFib patients experience fewer feelings of depression and anxiety.

READ MORE >
cardiologist preparing to perform radiofrequency ablation
Share on Twitter Share on Facebook Share on Linkedin

Another long-term benefit of AFib ablation: Improved mental health

Share on Twitter Share on Facebook Share on Linkedin
cardiologist preparing to perform radiofrequency ablation
A new study published in JAMA suggests catheter ablation can help AFib patients experience fewer feelings of depression and anxiety.
READ MORE >

Understanding reimbursements and coding for echocardiography

"I think everyone would agree that the current fee-for-service model is not working appropriately and there needs to be a fix," regulatory consultant Denise Garris explained in a new interview. 

READ MORE >
Video of Denise Garris, ASE regulatory consultant and principal of the Korris Group, explaining how reimbursements from insurance andMedicare work to pay or cardiac ultrasound exams. #ASE #ASE360 #ASE23 #ASE2023 #healthcarereimbursment
Share on Twitter Share on Facebook Share on Linkedin

Understanding reimbursements and coding for echocardiography

Share on Twitter Share on Facebook Share on Linkedin
Video of Denise Garris, ASE regulatory consultant and principal of the Korris Group, explaining how reimbursements from insurance andMedicare work to pay or cardiac ultrasound exams. #ASE #ASE360 #ASE23 #ASE2023 #healthcarereimbursment
"I think everyone would agree that the current fee-for-service model is not working appropriately and there needs to be a fix," regulatory consultant Denise Garris explained in a new interview. 
READ MORE >

In Other News

Florida nurse convicted in $200M Medicare fraud scheme, could spend decades in prison

Elizabeth Hernandez signed thousands of orders for unnecessary genetic tests and orthotic braces for patients she had not even examined, according to the DOJ.

READ MORE >
Judge bangs gavel
Share on Twitter Share on Facebook Share on Linkedin

Florida nurse convicted in $200M Medicare fraud scheme, could spend decades in prison

Share on Twitter Share on Facebook Share on Linkedin
Judge bangs gavel
Elizabeth Hernandez signed thousands of orders for unnecessary genetic tests and orthotic braces for patients she had not even examined, according to the DOJ.
READ MORE >

AI takes on hospital staffing to help battle burnout

Specialists with Providence Health System developed a new artificial intelligence algorithm to help make staffing schedules more flexible and predict patient volumes.

READ MORE >
Video of Natalie Edgworth at Providence Health System explaining how AI is used to optimizing staffing schedules. #HIMSS
Share on Twitter Share on Facebook Share on Linkedin

AI takes on hospital staffing to help battle burnout

Share on Twitter Share on Facebook Share on Linkedin
Video of Natalie Edgworth at Providence Health System explaining how AI is used to optimizing staffing schedules. #HIMSS
Specialists with Providence Health System developed a new artificial intelligence algorithm to help make staffing schedules more flexible and predict patient volumes.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TV star's family awarded $13M in malpractice case | Helping patients with ‘broken hearts’ | Cardiac amyloidosis in the spotlight
CMS proposes major TAVR changes | The real impact of RVU cuts in electrophysiology | Girl’s heart valve implanted upside down
News Alert: CMS proposes major TAVR changes
Cath lab kits recalled | Looking ahead to the future of FFR-CT | Medtronic completes major acquisition
FDA sees potential in heart failure software | SCCT & SCAI take on CT-derived FFR | Predicting long-term stroke risk
Abbott recalls heart monitoring tech | Redo TAVR with balloon-expandable valves | FDA clears new clot-removing device
Week in Review: Star Trek star's family awarded $13M | AI for cardiac amyloidosis | TAVR concerns | New CKM syndrome guidelines

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Current page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup